Aspartoacylase (ASPA) (N-Term) Peptide
ASPA
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN973518
Quick Overview for Aspartoacylase (ASPA) (N-Term) Peptide (ABIN973518)
Target
ASPA
(Aspartoacylase (ASPA))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-ASPA antibody (Catalog #: ARP56072_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- ASPA (Aspartoacylase (ASPA))
-
Background
-
The specific function of SASP is not yet known.This gene encodes an enzyme that catalyzes the conversion of N-acetyl_L-aspartic acid (NAA) to aspartate and acetate. NAA is abundant in the brain where hydrolysis by aspartoacylase is thought to help maintain white matter. This protein is an NAA scavenger in other tissues. Mutations in this gene cause Canavan disease. Alternatively spliced transcript variants have been found for this gene.
Alias Symbols: ACY2, ASP
Protein Interaction Partner: ASPA,ASPA
Protein Size: 313 -
Molecular Weight
- 36 kDa
-
Gene ID
- 443
-
NCBI Accession
- NM_000049, NP_000040
-
UniProt
- P45381
Target
-
You are here:
